Onsdag 12 Mars | 17:03:33 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2025-10-21 08:00 Kvartalsrapport 2025-Q3
2025-08-27 08:00 Kvartalsrapport 2025-Q2
2025-05-16 N/A X-dag ordinarie utdelning NANEXA 0.00 SEK
2025-05-15 N/A Årsstämma
2025-05-06 08:00 Kvartalsrapport 2025-Q1
2025-02-19 - Bokslutskommuniké 2024
2025-02-13 - Extra Bolagsstämma 2024
2024-11-07 - Kvartalsrapport 2024-Q3
2024-08-27 - Kvartalsrapport 2024-Q2
2024-05-16 - X-dag ordinarie utdelning NANEXA 0.00 SEK
2024-05-15 - Årsstämma
2024-05-03 - Kvartalsrapport 2024-Q1
2024-02-21 - Bokslutskommuniké 2023
2023-11-20 - Kvartalsrapport 2023-Q3
2023-08-23 - Kvartalsrapport 2023-Q2
2023-06-09 - Årsstämma
2023-05-30 - X-dag ordinarie utdelning NANEXA 0.00 SEK
2023-05-04 - Kvartalsrapport 2023-Q1
2023-02-16 - Bokslutskommuniké 2022
2022-10-25 - Kvartalsrapport 2022-Q3
2022-08-26 - Kvartalsrapport 2022-Q2
2022-06-10 - X-dag ordinarie utdelning NANEXA 0.00 SEK
2022-06-09 - Årsstämma
2022-04-20 - Kvartalsrapport 2022-Q1
2022-02-17 - Bokslutskommuniké 2021
2021-11-10 - Kvartalsrapport 2021-Q3
2021-08-20 - Kvartalsrapport 2021-Q2
2021-05-06 - Kvartalsrapport 2021-Q1
2021-05-03 - X-dag ordinarie utdelning NANEXA 0.00 SEK
2021-02-18 - Bokslutskommuniké 2020
2020-11-12 - Kvartalsrapport 2020-Q3
2020-08-20 - Kvartalsrapport 2020-Q2
2020-06-03 - X-dag ordinarie utdelning NANEXA 0.00 SEK
2020-06-02 - Årsstämma
2020-05-15 - Kvartalsrapport 2020-Q1
2020-02-28 - Bokslutskommuniké 2019
2019-11-12 - Kvartalsrapport 2019-Q3
2019-08-22 - Kvartalsrapport 2019-Q2
2019-06-12 - X-dag ordinarie utdelning NANEXA 0.00 SEK
2019-06-11 - Årsstämma
2019-05-15 - Kvartalsrapport 2019-Q1
2019-02-20 - Bokslutskommuniké 2018
2018-11-12 - Kvartalsrapport 2018-Q3
2018-08-22 - Kvartalsrapport 2018-Q2
2018-05-30 - X-dag ordinarie utdelning NANEXA 0.00 SEK
2018-05-29 - Årsstämma
2018-05-15 - Kvartalsrapport 2018-Q1
2018-02-20 - Bokslutskommuniké 2017
2017-11-10 - Kvartalsrapport 2017-Q3
2017-10-23 - Extra Bolagsstämma 2017
2017-08-24 - Kvartalsrapport 2017-Q2
2017-06-13 - X-dag ordinarie utdelning NANEXA 0.00 SEK
2017-06-12 - Årsstämma
2017-05-17 - Kvartalsrapport 2017-Q1
2017-02-15 - Bokslutskommuniké 2016
2016-11-16 - Kvartalsrapport 2016-Q3
2016-08-17 - Kvartalsrapport 2016-Q2
2016-05-27 - X-dag ordinarie utdelning NANEXA 0.00 SEK
2016-05-26 - Årsstämma
2016-05-12 - Kvartalsrapport 2016-Q1
2016-04-06 - Extra Bolagsstämma 2016
2016-02-25 - Bokslutskommuniké 2015
2015-11-19 - Kvartalsrapport 2015-Q3
2015-08-20 - Kvartalsrapport 2015-Q2

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriBioteknik
Nanexa är ett drug delivery-bolag med en egenutvecklad plattform som används för formulering av injicerbara depåläkemedel som skapar en tillförsel av läkemedel till blodet. PharmaShell processen baseras på ALD (Atomic Layer Deposition) teknologin som innesluter läkemedelspartiklar med ett tunt skal och skapar möjlighet för läkemedelsbolag att utveckla nya produkter. Nanexa har samarbete med flertalet läkemedelsbolag, huvudsakligen runtom den nordiska marknaden.
2025-02-13 15:40:00

The Extraordinary General Meeting (EGM) of Nanexa AB (publ) (the “Company”) has been held on February 13, 2025, at which meeting submitted proposals were passed. The complete proposals for resolutions are set out in the EGM notice.

In accordance with previously published information, the Board of Directors of Nanexa resolved on 24 January 2025 on a directed issue of units, subject to subsequent approval by the Extraordinary General Meeting. The EGM resolved today to approve the Board of Directors' resolution on a directed issue of a maximum of 7,712,121 units. Each unit consists of one (1) share and one (1) warrant. The right to subscribe for units shall, with deviation from the shareholders’ pre-emption rights, belong only to Nordic Issuing AB, for re-transfer to a limited number of investors pursuant to existing agreements. Each unit is issued at a price of SEK 0.1294 per unit, corresponding to the quota value for the Company’s share. However, the price to be used at re-transfer to the investors shall correspond to SEK 1.65 per unit, which corresponds to a subscription price of SEK 1.65 per share. The warrants are issued free of charge.

The directed issue will result in an increase in the number of shares in the Company by up to 7,712,121 shares, entailing an increase in the share capital of a maximum of approximately SEK 998,113.17. In addition, the directed issue includes a maximum of 7,712,121 warrants, which, if fully exercised, entitle to subscription of maximum 7,712,121 shares in the Company, whereby the share capital may increase by an additional maximum of approximately SEK 998,113.17.

The EGM resolved on a directed issue of a maximum of 6,666,667 warrants in order to secure the Company's commitments under the loan agreement entered into by the Company on January 23, 2025. The right to subscribe for warrants shall, with deviation from the shareholders' pre-emption rights, belong only to Buntel AB (3,358,334 warrants), Exelity AB (1,808,333 warrants), Aramia Capital AB (833,333 warrants), and Shaps Capital AB (666,667 warrants). The warrants are issued free of charge. Each warrant shall entitle the holder to subscribe for one new share in the Company at a subscription price of SEK 2.00. If all warrants are exercised for the subscription of shares, the Company's registered share capital will increase by approximately SEK 862,809.09.

The EGM further resolved to adopt the board of directors’ proposal regarding authorization for the board to decide on issues of shares, convertibles and warrants.